Remibrutinib (LOU064) in Sjogren's Syndrome: Safety and Efficacy Results from a 24-Week Placebo-controlled Proof-of-Concept Study
Remibrutinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Remibrutinib (LOU064) in Sjogren's Syndrome: Safety and Efficacy Results from a 24-Week Placebo-controlled Proof-of-Concept Study ### Output: Remibrutinib